Instant coffee and powdered milk are produced by spray drying. Fraunhofer researchers have adapted this technique to the tricky question of incorporating insoluble substances in core-shell particles. The new method helps reduce the concentration of active ingredients in therapeutic medications.
Encapsulation is used in cosmetics and pharmaceuticals to protect active ingredients against external influences such as aggressive gastric acid. Another use of encapsulation is to control the release of active ingredients inside the body: depending on the permeability of the shell material, the medication is delivered gradually rather than all at once. Because such systems release multiple, smaller doses over an extended period of time, the drug therapy is better tolerated and easier to administer. In some cases, it means taking just one pill a day instead of three.
Insoluble substances are a problem
The first step of the encapsulation process involves dissolving the active ingredient in a liquid medium and mixing it with the shell material. Then the solution is piped to an orifice in the center of a nozzle surrounded by an annular channel through which compressed air is injected at high speed. The pressure disperses the solution into an aerosol of fine droplets, which is then sprayed into a drying cylinder. Here, the liquid evaporates, leaving behind a fine powder of core-shell particles. The problem is that it is difficult to mix insoluble substances with other materials. This limits the choice of shell materials that can be used to produce the particles.
Three-way nozzle permits endless combinations of materials
“For this reason, we use a three-way nozzle to implement spraying. Its advantage is that it permits two substances to be fed separately to the nozzle. The shear forces mix the substances together at the orifice of the nozzle, creating an aerosol containing both materials,” explains Michael Walz, who developed and optimized the new technique with his colleague Dr. Achim Weber at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart.
This system permits endless combinations of materials, enabling the controlled release of active ingredients to be adapted to different applications. “We can modify the particle size and encapsulation efficiency by selecting the appropriate substances and by varying the concentration of the solution, the liquid volume flow, the drying temperature, and the pressure applied to the nozzle. This gives us the capability to respond to almost any customer requirement and develop solutions tailored to their needs,” says Weber.
The new process for the encapsulation of active ingredients could be of interest to fertilizer manufacturers and food processing companies as well as the cosmetics and pharmaceutical industries.
The Latest on: Drug delivery
- Global pharmaceutical drug delivery market is expected to grow with a CAGR of 4.9% over the forecast period from 2020-2026on June 25, 2020 at 5:46 pm
Reportlinker.com announces the release of the report "Pharmaceutical Drug Delivery Market: Global Industry Analysis, Trends, Market Size, and.
- Advanced & Targeted Drug Delivery Market begins to take bite out of Versioned Long Term Growthon June 25, 2020 at 7:32 am
Latest Study on Industrial Growth of Global Advanced & Targeted Drug Delivery Market 2019-2025. A detailed study accumulated to offer Latest insights about acute features of the Advanced & Targeted ...
- Nasal Drug Delivery Market Global Industry Size, Growth, Segments, Top Key Players, Revenue, Manufacturers and 2026 Forecast Research Reporton June 24, 2020 at 11:41 pm
The global “Nasal Drug Delivery Market Size” is prognosticated to reach USD 81.85 billion by 2026 attributable to ...
- Protein and RNA Used to Create Vesicles for Potential Drug Deliveryon June 24, 2020 at 1:00 pm
Scientists from the University at Buffalo and Iowa State University use protein, RNA to make hollow, spherical sacks called vesicles that could potentially be engineered to deliver drugs.
- Subcutaneous Biologics, Technologies and Drug Delivery Systems 2020-2030 - ResearchAndMarkets.comon June 23, 2020 at 3:24 am
The "Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030" report has been added to ResearchAndMarkets.com's offering. Biologics represent one of the fastest growing ...
- The Asia Pacific the pharmaceutical drug delivery market is anticipated to reach US$ 4,73,700.1 Mn by 2027 from US$ 2,77,589.9 Mn in 2019on June 22, 2020 at 5:51 am
The Asia Pacific the pharmaceutical drug delivery market is anticipated to reach US$ 4,73,700.1 Mn by 2027 from US$ 2,77,589.9 Mn in 2019. T ...
- Assessment of COVID-19's Effect on Needle-Free Drug Delivery Devices Market 2020-2024 | Technological Advances in Needle-Free Drug Delivery Devices to Augment Growth | Technavioon June 19, 2020 at 10:15 am
Technavio has announced its latest market research report titled Global Needle-free Drug Delivery Devices Market 2020-2024 (Graphic: Business Wire) LONDON-- ( BUSINESS WIRE )--Technavio has been ...
- Overcoming leukemia treatment resistance with nanoparticle drug delivery systemon June 18, 2020 at 4:05 pm
Lu is the CEO of Nami Therapeutics, a startup which designs nanoparticles for drug delivery in a variety of clinical contexts including cancer treatment and vaccine delivery. Because of its rate of ...
- Q&A: New technological innovations for drug delivery unveiledon June 18, 2020 at 6:38 am
How can new pharmaceuticals be delivered to market faster and what advantages can be gained from technological improvements to drug delivery? A leading professional offers his expertise.
- Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030on June 18, 2020 at 1:22 am
Reportlinker.com announces the release of the report "Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030" -.
via Google News and Bing News